Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Bosch

Showing results (231-240 of 364) with videos related to

Pageof 37
Sort By:
Journal of Hepatology|June 29, 2024
Metabolic phenotyping of patients with advanced chronic liver disease for better characterization of cirrhosis regressionYuly P Mendoza, Sofia Tsouka, Georg Semmler, et al.
Hepatology (Baltimore, Md.)|December 24, 2005
Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndromeManuel Hernández-Guerra, Eric López, Pablo Bellot, et al.
Ecohealth|March 13, 2010
The link between rapid enigmatic amphibian decline and the globally emerging chytrid fungusStefan Lötters, Jos Kielgast, Jon Bielby, et al.
Gut|March 2, 2011
Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosisAngelo Luca, Roberto Miraglia, Settimo Caruso, et al.
Hepatology Communications|August 11, 2018
Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver DiseaseCristina Margini, Giuseppe Murgia, Guido Stirnimann, et al.
Gut|December 16, 2014
KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statinsGiusi Marrone, Raquel Maeso-Díaz, Guillermo García-Cardena, et al.
Hepatology (Baltimore, Md.)|October 28, 2010
Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosisPablo Bellot, Juan Carlos García-Pagán, Rubén Francés, et al.
Journal of Hepatology|September 20, 2012
The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statinsGiusi Marrone, Lucia Russo, Eugenio Rosado, et al.
Gastroenterology|October 14, 2004
Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trialJaime Bosch, Dominique Thabut, Flemming Bendtsen, et al.
Gastroenterology|May 9, 2007
Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled studyJosé A Carrión, Miquel Navasa, Montserrat García-Retortillo, et al.
Pageof 37

Showing results (231-240 of 364) with videos related to

Sort By:
Pageof 37
Journal of Hepatology|June 29, 2024
Metabolic phenotyping of patients with advanced chronic liver disease for better characterization of cirrhosis regressionYuly P Mendoza, Sofia Tsouka, Georg Semmler, et al.
Hepatology (Baltimore, Md.)|December 24, 2005
Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndromeManuel Hernández-Guerra, Eric López, Pablo Bellot, et al.
Ecohealth|March 13, 2010
The link between rapid enigmatic amphibian decline and the globally emerging chytrid fungusStefan Lötters, Jos Kielgast, Jon Bielby, et al.
Gut|March 2, 2011
Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosisAngelo Luca, Roberto Miraglia, Settimo Caruso, et al.
Hepatology Communications|August 11, 2018
Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver DiseaseCristina Margini, Giuseppe Murgia, Guido Stirnimann, et al.
Gut|December 16, 2014
KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statinsGiusi Marrone, Raquel Maeso-Díaz, Guillermo García-Cardena, et al.
Hepatology (Baltimore, Md.)|October 28, 2010
Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosisPablo Bellot, Juan Carlos García-Pagán, Rubén Francés, et al.
Journal of Hepatology|September 20, 2012
The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statinsGiusi Marrone, Lucia Russo, Eugenio Rosado, et al.
Gastroenterology|October 14, 2004
Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trialJaime Bosch, Dominique Thabut, Flemming Bendtsen, et al.
Gastroenterology|May 9, 2007
Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled studyJosé A Carrión, Miquel Navasa, Montserrat García-Retortillo, et al.
Pageof 37